Supplements for Arthritis: Which Findings Are Useful?

Some supplements may offer additional relief from joint pain. The options depend on the condition: specific glucosamine, chondroitin, curcumin, and Boswellia products have been studied for knee osteoarthritis. For rheumatoid arthritis, omega-3 fatty acids are among the more extensively studied supplements. The formulation and the goal of treatment matter more than a long list of supposedly joint-friendly ingredients.

Positive results from individual trials do not necessarily translate into a treatment recommendation. The American College of Rheumatology’s September 2026 recommendations strongly advise against glucosamine, chondroitin, and their combination for knee, hip, or hand osteoarthritis. That broader assessment is worth discussing alongside the product-specific findings below. Supplements should not displace treatments with more dependable benefits.

What Joint Supplements Affect in the Body

Osteoarthritis involves the whole joint, including cartilage, bone, and surrounding tissue. Rheumatoid arthritis is an inflammatory autoimmune disease. Both can cause pain, but they need different treatment strategies. An ingredient involved in cartilage biology in the laboratory is not automatically a suitable treatment for every kind of joint pain.

Glucosamine

Glucosamine is an amino sugar and a building block of glycosaminoglycans, which form part of the cartilage matrix. In experiments, it influences processes including proteoglycan production and tissue breakdown. For an oral product, absorption, distribution, and clinical effects also matter. A substance’s presence in cartilage does not mean that taking more of it will rebuild damaged cartilage.

Chondroitin

Chondroitin sulfate helps retain water within the cartilage matrix, contributing to the tissue’s ability to withstand load. It is only partly absorbed when taken orally, and estimates of bioavailability depend on the product and measurement method. Researchers have investigated both symptom relief and possible effects on structural changes in the joint.

MSM

Methylsulfonylmethane, or MSM, is a sulfur-containing compound. Experimental studies describe effects on inflammation and oxidative processes. Clinical trials in knee osteoarthritis are smaller and shorter than those for some other joint supplements. They mainly offer preliminary evidence about pain and physical function.

Curcumin

Curcumin is a compound found in turmeric root. In the laboratory, it affects several inflammatory signaling pathways, including NF-κB. Conventional curcumin is poorly absorbed. Many trials therefore use specialized formulations whose results cannot simply be transferred to turmeric powder or any capsule on the shelf.

Omega-3 Fatty Acids

EPA and DHA are long-chain omega-3 fatty acids. They can become part of cell membranes and serve as starting materials for signaling molecules involved in inflammation and its resolution. This is a particular research interest in rheumatoid arthritis, where inflammation drives disease. A supplement does not replace disease-modifying treatment.

Boswellia

Boswellia extracts come from frankincense resin. Their constituents include boswellic acids, which can affect 5-lipoxygenase and other inflammatory processes in experimental systems. Studies using a clearly specified extract are more informative about practical benefits than the mechanism alone.

What Research Shows About Each Supplement

Glucosamine: A Combination Compared With Celecoxib

The MOVES trial involving 606 participants compared glucosamine hydrochloride plus chondroitin sulfate with celecoxib in people with knee osteoarthritis. After six months, the WOMAC pain score fell by 50.1% with the combination and 50.2% with celecoxib. The trial tested whether the combination was no worse than the medication by more than a prespecified margin, and met that criterion. There was no placebo group. These findings concern this combination under these study conditions; they do not establish that every glucosamine product works as well as celecoxib.

Meta-analyses give a less consistent picture. A 2018 review of 30 randomized trials found that chondroitin reduced pain compared with placebo, while the combination did not show a consistent pain advantage. An eight-trial analysis published online in 2022 and in print in 2023 found an improvement in the combined WOMAC score versus placebo, but no statistically clear difference on the visual analog pain scale. Formulations and trial designs may contribute to these differences, but they cannot automatically explain away every negative result.

Chondroitin: Symptoms and Possible Structural Effects

Some trials of defined chondroitin products have reported symptom improvements. A separate MRI pilot study followed 69 people with knee osteoarthritis and signs of synovitis. Participants received chondroitin or placebo for six months; both groups then received chondroitin during a six-month open-label phase. The original chondroitin group had less cartilage volume loss on MRI, with differences visible at six months, but symptoms were similar between groups. This is an interesting structural signal, not proof that an over-the-counter product stops osteoarthritis.

Two questions therefore need to stay separate: does an everyday activity become easier, and is there reliable evidence of a long-term effect on the disease? The first is more accessible to an individual treatment trial than the second.

MSM: Small Twelve-Week Trials

In a pilot trial of 50 adults with knee osteoarthritis, 6 g of MSM a day, taken in two doses, improved pain and physical function compared with placebo after 12 weeks. Another study using approximately 3.4 g a day found better physical function, but the between-group differences in WOMAC pain and stiffness were not statistically clear.

These findings provide a reason for further research. They are more limited than a claim that MSM reliably treats all joint pain. There is considerably less evidence about benefits and safety over longer periods.

Curcumin: Osteoarthritis and Rheumatoid Arthritis

A meta-analysis of six randomized studies in rheumatoid arthritis reported improvements in several measures of disease activity and inflammation. A 2021 review of 11 trials in knee osteoarthritis also found evidence of symptom relief.

The products, comparison groups, and study quality varied. Individual comparisons with anti-inflammatory pain medications cannot establish that curcumin is interchangeable with those medicines. Any possible benefit needs to be considered as an adjunct suited to the particular condition and treatment plan.

Omega-3s: The Main Joint Research Concerns Rheumatoid Arthritis

A meta-analysis of ten trials using at least 2.7 g of omega-3 fatty acids a day for at least three months found lower use of nonsteroidal anti-inflammatory drugs, or NSAIDs. The reduction in tender joint count was not statistically clear. A later analysis of 23 studies found small estimated effects, with confidence intervals for pain and joint counts that included no benefit. Most evidence was rated low or very low certainty; the authors also raised concerns about inadequate blinding in earlier findings on pain-medication use.

Needing fewer additional pain medications could be useful. The evidence does not establish omega-3 supplements as a stand-alone treatment for rheumatoid arthritis, or justify reducing prescribed medicines without a treatment review. Results in rheumatoid arthritis also should not be assumed to apply to osteoarthritis.

Boswellia: Encouraging Osteoarthritis Findings

A meta-analysis of seven randomized trials involving 545 participants found better scores for pain, stiffness, and function. Most trials were small and relatively short. Whether a product contains the extract actually studied is therefore an important part of interpreting the findings.

Dose, Timing, and Formulation

Glucosamine: The Salt Form Is Part of the Evidence

Crystalline glucosamine sulfate has often been studied at 1,500 mg a day. In the six-month GUIDE trial involving 318 participants, this formulation improved symptoms compared with placebo. Two older trials, by Reginster and Pavelka, each lasted three years and also reported differences in joint-space narrowing measured on X-rays.

Those findings need to remain attached to the formulation tested. Results for glucosamine hydrochloride have been less consistent overall, although it was part of the MOVES combination. The salt form is useful when comparing studies, but it does not by itself prove or disprove effectiveness. The positive trials also need to be read alongside the broader guideline assessment described above.

Chondroitin: Quality and Composition

Trials have often used 800–1,200 mg of chondroitin sulfate daily. Pharmaceutical-grade preparations with a defined composition are easier to compare with study products than supplements of uncertain purity. A label such as “joint complex” tells you little about that match.

These research doses are not a personal dosing recommendation. Before a trial, it should be clear which product is being considered and whether other medications or medical conditions affect the decision.

MSM: Different Daily Amounts

The studies described here used approximately 3.4–6 g daily for 12 weeks, sometimes divided into several doses. A higher amount is not necessarily better. Short trials offer only limited guidance about prolonged use.

Curcumin: Absorption and Safety Belong Together

Some studies use 500–1,000 mg daily of a specialized curcumin formulation. Different delivery systems make these amounts difficult to compare directly. A small, older pharmacokinetic study reported roughly 20-fold higher measured bioavailability when 20 mg of piperine was given with curcumin. That describes absorption under those conditions, not a 20-fold greater effect on joint pain.

Piperine can also affect how the body handles medications. Better absorption needs to be weighed against tolerability and interactions. Rare liver injuries have been reported with medicinal turmeric and curcumin products, with potentially greater risk from enhanced-absorption or high-dose formulations. This is different from using turmeric in food. Jaundice or dark urine while taking a supplement warrants stopping it and seeking medical advice.

Fish Oil: Count EPA and DHA, Not Total Oil

The EPA and DHA content matters when comparing capsules. One gram of fish oil does not automatically contain one gram of these fatty acids. The higher amounts used in rheumatoid arthritis trials should be discussed with the treating clinician, especially when other conditions or anticoagulant medications are involved.

Many trials lasted at least 12 weeks. Their results do not support expecting reliable immediate pain relief from a single dose.

Combinations and Other Approaches

Glucosamine, chondroitin, and MSM are often sold together. Trials of a two-ingredient combination do not establish that adding MSM improves it. Nor does the MOVES result apply to any mixture assembled from the same general ingredient categories.

Collagen peptides are also being studied for joints and connective tissue, in different populations and for different outcomes. More ingredients do not necessarily produce greater benefit. They can make it harder to identify what, if anything, is helping.

Why Responses Differ

The type and severity of arthritis, joint loading, other treatments, and the particular product can all affect the changes someone notices. With advanced joint damage, it is especially useful to distinguish possible symptom relief from an expectation that cartilage will regrow.

Changes in the starting symptoms matter too. Someone who adjusts their exercise, gains strength, or changes pain-medication use may improve for several reasons at once. No simple blood test reliably selects the right joint supplement. A normal CRP result, for example, does not establish that glucosamine is the right choice.

How to Evaluate a Treatment Trial

Inflammation Markers

CRP and erythrocyte sedimentation rate can help monitor inflammatory joint disease. A single decrease does not prove that a supplement is working: infections, other conditions, and the rest of the treatment plan affect these measures as well. In osteoarthritis, pain, mobility, and specific daily activities are often closer to the outcome that matters.

Uric Acid

A suddenly painful, swollen joint may be caused by gout, but there are other possibilities, including infection. Prompt medical assessment is more useful than trying a cartilage supplement in this situation. A single uric acid result cannot reliably confirm or rule out an acute gout attack.

Kidney and Liver Function

Whether blood tests are needed depends on existing conditions, medications, symptoms, and the product. A large laboratory panel is not a prerequisite for every supplement trial. Known kidney or liver disease does call for more careful selection.

Choosing and Adjusting a Plan

A manageable trial starts with a concrete goal, such as walking farther with less pain. Making as few other changes as practical helps with interpretation. After an agreed period, consider the benefit, side effects, and cost together. If there is no improvement, reassessing the diagnosis and treatment plan is often more useful than adding more capsules.

Frequently Asked Questions

Which Supplements Can Relieve Osteoarthritis Pain?

Certain glucosamine, chondroitin, curcumin, and Boswellia products have positive trial results, but findings differ by product and study. There is no dependable ranking for everyone. The 2026 ACR recommendations advise against glucosamine, chondroitin, and their combination for knee, hip, and hand osteoarthritis, so a positive individual study should not be read as a routine recommendation.

What Might Help Alongside Rheumatoid Arthritis Treatment?

Omega-3 fatty acids have been studied for symptoms and the need for additional pain medication. Curcumin is also under investigation. Neither replaces treatment that controls the disease course.

What Makes Sense for Sports-Related Joint Pain?

First, establish what is causing the pain. Training load, recovery, and injury all matter. Osteoarthritis trials do not automatically apply to otherwise healthy, physically active people. Research on MSM, curcumin, or collagen addresses more specific questions.

How Long Might an Effect Take?

Many trials assess results after four to twelve weeks, which is a more realistic research timeframe than a few days. The duration of an individual trial depends on the product, symptoms, and treatment plan; some studies run longer.

Can These Products Be Combined With Pain Medication?

Sometimes, but the full medication list needs to be considered. Interactions deserve particular attention with anticoagulants, before surgery, or during cancer treatment. The word “natural” does not answer the safety question.

Does It Have to Be Pharmaceutical Grade?

A traceable composition and relevant trial data make a product easier to assess. A familiar brand name alone is not enough. Conversely, being sold over the counter does not automatically mean a product cannot have an effect.

Which Supplement Fits an Elevated Inflammation Marker?

An elevated result first needs an explanation. It does not automatically point to curcumin, fish oil, or Boswellia. The diagnosis and existing treatment determine the next steps.

What Should Be Checked if Pain Persists?

That depends on the symptoms. A joint examination, the history over time, and, where appropriate, imaging or targeted blood tests may be more useful than switching supplements again. Sudden major swelling, warmth, or symptoms such as fever should be assessed promptly.

Sources

• Hochberg MC, Martel-Pelletier J, Monfort J, Möller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Doménech G, Henrotin Y, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP, MOVES Investigation Group (2016). Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Annals of the rheumatic diseases, 75(1), 37-44. https://doi.org/10.1136/annrheumdis-2014-206792 | Source

• Zhu X, Sang L, Wu D, Rong J, Jiang L (2018). Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials. Journal of orthopaedic surgery and research, 13(1), 170. https://doi.org/10.1186/s13018-018-0871-5 | Source

• Meng Z, Liu J, Zhou N (2023). Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis. Archives of orthopaedic and trauma surgery, 143(1), 409-421. https://doi.org/10.1007/s00402-021-04326-9 | Source

• Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Abram F, Dorais M, Pelletier JP (2011). Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Annals of the rheumatic diseases, 70(6), 982-9. https://doi.org/10.1136/ard.2010.140848 | Source

• Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF (2006). Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis and cartilage, 14(3), 286-94. https://doi.org/10.1016/j.joca.2005.10.003 | Source

• Debbi EM, Agar G, Fichman G, Ziv YB, Kardosh R, Halperin N, Elbaz A, Beer Y, Debi R (2011). Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC complementary and alternative medicine, 11, 50. https://doi.org/10.1186/1472-6882-11-50 | Source

• Kou H, Huang L, Jin M, He Q, Zhang R, Ma J (2023). Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis. Frontiers in immunology, 14, 1121655. https://doi.org/10.3389/fimmu.2023.1121655 | Source

• Hsiao AF, Lien YC, Tzeng IS, Liu CT, Chou SH, Horng YS (2021). The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis. Complementary therapies in medicine, 63, 102775. https://doi.org/10.1016/j.ctim.2021.102775 | Source

• Lee YH, Bae SC, Song GG (2012). Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Archives of medical research, 43(5), 356-62. https://doi.org/10.1016/j.arcmed.2012.06.011 | Source

• Gkiouras K, Grammatikopoulou MG, Myrogiannis I, Papamitsou T, Rigopoulou EI, Sakkas LI, Bogdanos DP (2024). Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis’ disease activity indicators: a systematic review and meta-analysis of randomized placebo-controlled trials. Critical reviews in food science and nutrition, 64(1), 16-30. https://doi.org/10.1080/10408398.2022.2104210 | Source

• Yu G, Xiang W, Zhang T, Zeng L, Yang K, Li J (2020). Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC complementary medicine and therapies, 20(1), 225. https://doi.org/10.1186/s12906-020-02985-6 | Source

• Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, Blanco FJ, Benito P, Martín-Mola E, Paulino J, Marenco JL, Porto A, Laffon A, Araújo D, Figueroa M, Branco J (2007). Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis and rheumatism, 56(2), 555-67. https://doi.org/10.1002/art.22371 | Source

• Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C (2001). Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet (London, England), 357(9252), 251-6. https://doi.org/10.1016/S0140-6736(00)03610-2 | Source

• Pavelká K, Gatterová J, Olejarová M, Machacek S, Giacovelli G, Rovati LC (2002). Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Archives of internal medicine, 162(18), 2113-23. https://doi.org/10.1001/archinte.162.18.2113 | Source

• Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta medica, 64(4), 353-6. https://doi.org/10.1055/s-2006-957450 | Source

• Persiani S, Roda E, Rovati LC, Locatelli M, Giacovelli G, Roda A (2005). Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis and cartilage, 13(12), 1041-9. https://doi.org/10.1016/j.joca.2005.07.009 | Source

• American College of Rheumatology (2026). 2026 Update of the American College of Rheumatology Recommendations for the Management of Osteoarthritis of the Knee, Hip, and Hand. https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/bltb3d12c34020da842/oa-guideline-summary-2026.pdf

• Therapeutic Goods Administration (2023). Medicines containing turmeric or curcumin - risk of liver injury. https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/medicines-containing-turmeric-or-curcumin-risk-liver-injury